Mindbytes Jul 8, 2026
CRISPR Expands From One Approval Into a Full Clinical Pipeline in 2026
CRISPR gene editing enters mainstream medicine as Casgevy approval fuels a clinical trial pipeline for cancer, rare diseases, and autoimmune conditions with FDA cutting red tape.
Linsey